Semi-Annual Balance Sheet

Carna Biosciences, Inc. - Filing #7722864

Concept As at
2018-06-30
As at
2017-12-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,519,562,000 JPY
1,856,218,000 JPY
Other
103,474,000 JPY
67,779,000 JPY
Current assets
1,842,515,000 JPY
2,134,250,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
17,083,000 JPY
20,381,000 JPY
Intangible assets
Intangible assets
294,000 JPY
405,000 JPY
Investments and other assets
Investments and other assets
99,146,000 JPY
35,349,000 JPY
Non-current assets
116,523,000 JPY
56,136,000 JPY
Assets
1,959,039,000 JPY
2,190,386,000 JPY
Liabilities
Current liabilities
Accounts payable - trade
1,088,000 JPY
3,026,000 JPY
Income taxes payable
13,293,000 JPY
19,259,000 JPY
Other
13,511,000 JPY
12,956,000 JPY
Current liabilities
390,841,000 JPY
341,966,000 JPY
Accounts payable - other
86,521,000 JPY
124,727,000 JPY
Non-current liabilities
Non-current liabilities
583,886,000 JPY
470,511,000 JPY
Bonds payable
130,000,000 JPY
144,000,000 JPY
Long-term borrowings
425,321,000 JPY
298,122,000 JPY
Asset retirement obligations
26,440,000 JPY
26,179,000 JPY
Other
2,125,000 JPY
2,209,000 JPY
Liabilities
974,728,000 JPY
812,477,000 JPY
Other liabilities
Other liabilities
Net assets
Share capital
3,275,296,000 JPY
3,226,487,000 JPY
Shareholders' equity
Capital surplus
Capital surplus
2,093,321,000 JPY
2,044,512,000 JPY
Retained earnings
Retained earnings
-4,396,591,000 JPY
-3,906,897,000 JPY
Treasury shares
-117,000 JPY
-99,000 JPY
Shareholders' equity
971,909,000 JPY
1,364,003,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-552,000 JPY
-55,000 JPY
Valuation and translation adjustments
-2,651,000 JPY
-1,186,000 JPY
Net assets
984,310,000 JPY
1,377,908,000 JPY
Share acquisition rights
15,052,000 JPY
15,092,000 JPY
Liabilities and net assets
1,959,039,000 JPY
2,190,386,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.